Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases

Pierre Payoux; Jean-Philippe Ranjeva

doi:10.1016/j.therap.2020.12.008

Journal Articles Thérapie Year : 2021

Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases

(1) , (2, 3)

1
2
3

Pierre Payoux

Function : Author

Toulouse Neuro Imaging Center

Jean-Philippe Ranjeva

Function : Author
PersonId : 757779
ORCID : 0000-0001-8073-102X
IdRef : 11434938X

Centre de résonance magnétique biologique et médicale

Centre d'Exploration Métabolique par Résonance Magnétique [Hôpital de la Timone - AP-HM]

Domains

Life Sciences [q-bio] Bioengineering Imaging

Jean-Philippe RANJEVA : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03500764

Submitted on : Wednesday, December 22, 2021-3:20:49 PM

Last modification on : Tuesday, January 10, 2023-3:12:20 AM

Dates and versions

hal-03500764 , version 1 (22-12-2021)

Identifiers

HAL Id : hal-03500764 , version 1
DOI : 10.1016/j.therap.2020.12.008

Cite

Pierre Payoux, Jean-Philippe Ranjeva. Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases. Thérapie, 2021, 76 (2), pp.121-126. ⟨10.1016/j.therap.2020.12.008⟩. ⟨hal-03500764⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-TLSE2 CNRS UNIV-AMU CRMBM UNIV-UT3 UT3-TOULOUSEINP

4 View

0 Download

Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share